Download - DIC DNB obg Theory Question Dec 2007
1
DNB OBS AND GYN THEORY QUESTION DEC 2007 -
DISSEMINATED INTRAVASCULAR COAGULATION – DESCRIBE ITS CAUSES, PATHOGENESIS AND
MANAGEMENT ( 10 MARKS )
DNBCENTRAL.INWWW.DNBCENTRAL.IN
WWW.DNBCENTRAL.IN 2
• DEFINITION• ETIOLOGY• PATHOPHYSIOLOGY• CLINICAL MANIFESTATIONS• LABORATORY FINDINGS• DIFFERENTIAL DIAGNOSIS• TREATMENT
WWW.DNBCENTRAL.IN 3
DEFINITIONIT IS AN ACQUIRED CONDITION IN WHICH
NORMAL PHYSIOLOGY OF COAGULATION IS DISTURBED LEADING TO WIDESPREAD INTRAVASCULAR COAGULATION PROCESS ASSOCIATED WITH INJURY TO MICROVASCULATURE WHICH RESULTS IN ORGAN DYSFUNCTION, CAPILLARY LEAK & SHOCK.
WWW.DNBCENTRAL.IN 4
MECHANISMSOccurs due to simultaneous action of the following 4 mechanisms
1) Increased thrombin generation2) Suppressed physiological anticoagulant pathways3) Activation & subsequent impairment of fibrinolysis4) Activation of inflammatory pathways
WWW.DNBCENTRAL.IN 5
ETIOLOGY INFECTIOUS:
Meningococcemia- purpura fulminans
Bacterial sepsis- staphylococcal, streptococcal, E coli Rickettsia- Rocky Mountain spotted fever
Viral- CMV, varicella, arboviruses
Malaria, Candida, Aspergillus TISSUE INJURY:
Multiple fractures with fat emboli, crush injury, head injury MALIGNANCY:
Acute promyelocytic leukemia, acute myeloid leukemia, neuroblastoma
VENOM OR TOXIN:
Snake bites, insect bites
WWW.DNBCENTRAL.IN 6
CONTD… MICROANGIOPATHIC DISORDERS:
TTP, HUS, Kasabach-Meritt syndrome GI DISORDERS:
Fulminant hepatitis, Inflammatory bowel disease, Pancreatitis HEREDITARY THROMBOTIC DISORDERS:
Antithrombin III deficiency, Homozygous protein C deficiency NEWBORN:
Maternal toxemia, Abruptio placentae, Necrotizing enterocolitis, Erythroblastosis fetalis
MISCELLANEOUS:
Acute graft rejection, Acute hemolytic transfusion reaction, Collagen vascular disorders, Heparin induced thrombosis, hyperpyrexia
WWW.DNBCENTRAL.IN 7
WWW.DNBCENTRAL.IN 8
PATHOPHYSIOLOGY
WWW.DNBCENTRAL.IN 9
CLINICAL MANIFESTATIONS
DIC
NON OVERT DIC OVERT DIC ACUTE DIC CHRONIC DIC
CONTROLLED UNCONTROLLED
WWW.DNBCENTRAL.IN 10
Non overt DIC:
Stressed & compensated hemostatic system. Lab tests- abnormal but no clinical manifestations.
Overt DIC:
Stressed and decompensated hemostatic system. Lab tests- abnormal with clinical bleeding or micro vascular thrombosis and organ dysfunction.
Further divided into controlled and uncontrolled based on whether the process will resolve when the underlying condition is removed.
WWW.DNBCENTRAL.IN 11
Acute DIC:
• Bleeding from vein puncture site, surgical wound.• Grayish discoloration of tips of fingers, toes &
ears in a symmetrical distribution.• Meningococcemia(PURPURA FULMINANS)-
bleeding from GI tract, gingival bleeding, epistaxis, pulmonary hemorrhage, hematuria.
WWW.DNBCENTRAL.IN 12PURPURA FULMINANS
WWW.DNBCENTRAL.IN 13
Chronic DIC:
• Superficial and extensive ecchymosis of extremities without petechiae which may be intermittent or can persist.
• Recurrent episodes of epistaxis or internal mucosal bleeding.
• Trousseau sign- Recurrent migratory thrombophlebitis in association with cancer.
• Impairment of renal function, confusion, repeated episodes of cerebral thrombosis.
WWW.DNBCENTRAL.IN 14CHRONIC DIC
WWW.DNBCENTRAL.IN 15
WWW.DNBCENTRAL.IN 16
PURPURA FULMINANS OF A CHILD'S LEG
WWW.DNBCENTRAL.IN 17
Specific features of DIC in neonates and infants
CAUSES:
• Transplacental passage of thromboplastin or other procoagulant substances in neonates born of mothers affected with DIC owing to abruptio placenta, eclampsia or septicemia
• Development of DIC in a twin fetus may be due to feto-fetal passage of thromboplastin.
• DIC secondary to hemangioma . PRECIPITATING FACTOR:
Asphyxia, septicemia, eclampsia
WWW.DNBCENTRAL.IN 18
CLINICAL FEATURES: Symmetric ecchymosis of lower extremities and
buttocks. Later these lesions become necrotic ultimately forming blood filled bullae.
Sharply circumscribed infarcts of skin and genitalia Gangrene of extremities involves digits symmetrically. Fever and prostration Mortality 40-70% TREATMENT: Heparin. Relapse common after cessation.
WWW.DNBCENTRAL.IN 19
BULLAE SEEN IN DIC
WWW.DNBCENTRAL.IN 20
LABORATORY FINDINGS
COMPLETE BLOOD COUNT:
Severe thrombocytopenia(50000-100000/µl) with or without anemia
PERIPHERAL BLOOD SMEAR:
Schistocytes- Microangiopathic hemolysis
PROTHROMBIN TIME & aPTT:
Prolonged in early cases but may be normal or short in chronic cases
FIBRINOGEN LEVEL:
Low
WWW.DNBCENTRAL.IN 21
SCHISTOCYTES IN PERIPHERAL BLOOD SMEAR
WWW.DNBCENTRAL.IN 22
D dimer, FIBRINOGEN / FIBRIN DEGRADATION PRODUCTS:
Increased >25µg fibrinogen equivalents/ml
PROTEIN C & S, ANTITHROMBIN:
decreased
MARKERS OF ENDOGENOUS THROMBIN GENERATION:
Prothrombin fragment 1.2 and
Thrombin-Antithrombin complexes(TATs) are elevated
WWW.DNBCENTRAL.IN 23
Overt DIC Scoring System
WWW.DNBCENTRAL.IN 24
DIFFERENTIAL DIAGNOSIS
Primary fibrinogenolysis or Pathologic fibrinolysis:
Platelet count is normal
D dimer may be normal or minimally increased
No hypoprothombinemia & No deficiency of coagulation factors (VII, IX, X, XI)
Severe liver disease:
D dimer test is normal
WWW.DNBCENTRAL.IN 25
TREATMENT
BLOOD COMPONENT THERAPY:
INDICATIONS:Active bleedingInvasive procedureRisk of bleeding complication
GOALS: To maintainPlatelet count >50000/µlFibrinogen concentration >1g/LProthrombin values less than double the normal range
WWW.DNBCENTRAL.IN 26
FRESH FROZEN PLASMA(FFP):
Constituents:
0.7-1.0 U/ml of factors II,V, VII, VIII, X, XI, XII, XIII and2.5mg/ml fibrinogen.
Dosage: 15ml/kg
CRYOPRECIPITATE: Constituents;
fibrinogen 150mg/bagfactor VIII 80-120units/bagfactor XIII & vWB
Dosage: 1 bag/5kg body wt.
WWW.DNBCENTRAL.IN 27
PLATELETS:
Random donor platelets(RDP):
• Constituents:
5.5×10¹° platelets
• Dosage:
1 unit/ 10 kg Single donor platelets:
• Constituents:
3×10¹¹ platelets
FRESH BLOOD:
Indicated in severe trauma to replace acute massive blood loss.
WWW.DNBCENTRAL.IN 28
ANTICOAGULANT THERAPY: Heparin and other anticoagulant therapy to inhibit thrombin.
Indicated in patients with clinically overt thromboembolism , chronic DIC and extensive fibrin deposition.
Dosage:
Weight < 30kg – 10U/kg/hr
Weight > 30kg – 4U/kg/hr
WWW.DNBCENTRAL.IN 29
REPLACEMENT OF NATURAL ANTICOAGULANT PATHWAYRecombinant human activated protein c 24µg/kg/hr.
Adverse effects include bleeding.
ANTI-THROMBIN INDEPENDENT INHIBITORS desirudin
gabexate mesylate
WWW.DNBCENTRAL.IN 30
COMPLICATIONS
Respiratory failureRenal failureStrokeCardiac tamponadeHemothorax
WWW.DNBCENTRAL.IN 31
PROGNOSIS
• Since DIC is a result of an acute medical illness, prognoses depends almost entirely upon the speed of the intensivist in handing the bleeding emergency, as well as the ability to treat the underling disorder
• The underlying disease that causes the disorder will usually predict the probable outcome.
WWW.DNBCENTRAL.IN 32
Thank you
www.DnbCentral.in